Olaparib Plus Trastuzumab in HER2-positive Advanced Breast Cancer Patients with Germline BRCA1/2 Mutations: the OPHELIA Phase 2 Study
BREAST(2024)
Key words
HER2-Positive,Advanced breast cancer,BRCA mutation,Olaparib,Trastuzumab
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined